{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Management Strategies for STE-ACS

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe treatment decisions related to use of primary percutaneous coronary intervention (PPCI), bare metal stents (BMS), and drug-eluting stents (DES) for STE-ACS.
  2. Recognize appropriate use of antiplatelets, anticoagulants, and oxygen in acute management of STE-ACS.
  3. Select analgesic and cardioprotective medications as well as stabilization therapies in management of STE-ACS in a case scenario.
Price: $21.95


  • ANCC 2.0 CH / 1.5 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: NP0621B
Published: Jun 2021
Expires: 6/2/2023
Required Passing Score: 7/10 (70%)
Authors: Mohamed Toufi c El Hussein, PhD, RN, NP; Jonah Hakkola